Latest filing published 19 Feb 2016 for GLOBEIMMUNE INC, €6,863.
Insider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -31.0%Entry US$7.00 · Close at T+365 US$4.83
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Healthcare Ventures VII LP: trading record in brief
Healthcare Ventures VII LP is a declared insider at 4 companies; the most frequent names are Globeimmune Inc, Tetralogic Pharmaceuticals Corp and Altimmune, Inc. In total, 24 filings cover trades dated from 3 August 2007 to 19 February 2016.
Market trades split into 5 purchases (€7.1M) and 6 sales (€41k). Purchases outweigh sales by €7.1M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. So far in 2016, the count stands at no purchases and 6 sales.
In size, the median ticket on the buying side is €694k.
The record was last updated on 19 February 2016 with an open-market sale (€6,863) in Globeimmune Inc. The latest purchase dates back some time: it was published 4,507 days ago, on 8 July 2014. Publication is fast: at least half of the trades appear on SEC (Form 4) on the same day. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Healthcare Ventures VII LP
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,000 shares@ US$1.530.0% of flowCommon StockSEC:0001209191-16-100441:0
- 5,000 shares@ US$1.400.0% of flowCommon StockSEC:0001209191-16-100441:1
- 5,000 shares@ US$1.390.0% of flowCommon StockSEC:0001209191-16-100441:2
- 5,000 shares@ US$1.7235.6% of flowCommon StockSEC:0001209191-16-098769:0
- 5,000 shares@ US$1.5131.6% of flowCommon StockSEC:0001209191-16-098769:2
- 5,000 shares@ US$1.5932.8% of flowCommon StockSEC:0001209191-16-098769:1
- 80,533 shares0Common StockSEC:0001209191-14-046450:0
- 188,096 shares0Common StockSEC:0001209191-14-046450:1
- 123,574 shares0Common StockSEC:0001209191-14-046450:2
- 2,064 shares0Common StockSEC:0001209191-14-046450:3
- 190,000 shares@ US$10.00Common StockSEC:0001209191-14-046450:4Canonical exit: 6 Oct 2014 (T+90)
- 653,594 shares0Common StockSEC:0001209191-13-057535:0
- 438,453 shares0Common StockSEC:0001209191-13-057535:1
- 506,086 shares0Common StockSEC:0001209191-13-057535:2
- 7,335 shares@ US$6.4022Common StockSEC:0001209191-13-057535:3
- 267,535 shares@ US$7.00Common StockSEC:0001209191-13-057535:4
- 713,463 shares@ US$7.00Common StockSEC:0001209191-13-057535:5Canonical exit: 17 Mar 2014 (T+90)
- 935,814 shares@ US$2.5417Common StockSEC:0001209191-10-053325:0
- 3,067,243 shares0Common Stock, $.0001 par value per shareSEC:0001231919-07-000111:1
- 125,000 shares@ US$7.66Common Stock, $.0001 par value per shareSEC:0001231919-07-000064:0Canonical exit: 1 Nov 2007 (T+90)
- 3,047,174 shares0Common Stock, $.0001 par value per shareSEC:0001231919-07-000064:1
- 125,000 shares@ US$7.66Common Stock, $.0001 par value per shareSEC:0001231919-07-000065:0Canonical exit: 1 Nov 2007 (T+90)
- 3,047,174 shares0Common Stock, $.0001 par value per shareSEC:0001231919-07-000065:1
23 of 23 declarations
